Health
Health and Drug Approval
Regeneron's drug for an ultra-rare disease that causes dangerous bone growth has been approved by regulators.
Coverage timeline — 1 article
STAT News
A Regeneron drug that treats an ultra-rare disease that causes bone to form where it's not meant to be has won approval.
2026-08-19 17:02 UTC